APA (7th ed.) Citation

NS, R., MJ, D., R, S., B, C., JS, T., AM, H., & IH, K. (2026). Response to Machiels et al. reconsidering the role of PMRT in low to intermediate risk breast cancer: Applying results from previous standards of treatments in the current multimodal practice. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 220, 111542. https://doi.org/10.1016/j.radonc.2026.111542

Chicago Style (17th ed.) Citation

NS, Russell, Dixon MJ, Sainsbury R, Chua B, Thomas JS, Hanby AM, and Kunkler IH. "Response to Machiels Et Al. Reconsidering the Role of PMRT in Low to Intermediate Risk Breast Cancer: Applying Results from Previous Standards of Treatments in the Current Multimodal Practice." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 220 (2026): 111542. https://doi.org/10.1016/j.radonc.2026.111542.

MLA (9th ed.) Citation

NS, Russell, et al. "Response to Machiels Et Al. Reconsidering the Role of PMRT in Low to Intermediate Risk Breast Cancer: Applying Results from Previous Standards of Treatments in the Current Multimodal Practice." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 220, 2026, p. 111542, https://doi.org/10.1016/j.radonc.2026.111542.